Sapropterin

N/A

Report date: 2022/08/29 20:00:24

Base Information

Drug NameSapropterin
Drug Alias Name沙丙蝶呤四氢生物蝶呤ETX-101ETX-101(Etx Pharma)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhenylalanine hydroxylase agonists
TargetsPhenylalanine hydroxylase
Therapy Area/IndicationsDiabetic GastroparesisGastroparesis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesEtx PharmaUniversity Of Texas Medical Branch
China Registration ClassN/A

Develop Information

Active CompaniesEtx Pharma
Inactive CompaniesN/A
Active IndicationsDiabetic GastroparesisGastroparesis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A